1. O1–11–01: Gamma‐secretase inhibitor (GSI) and modulator (GSM) photoaffinity probes reveal distinct binding sites on presenilin. (1st July 2013) Authors: Johnson, Doug; Bales, Kelly; Pozdnyakov, Nikolay; Murrey, Heather; Pettersson, Martin; Crump, Christina; Yueming, Li Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 4 Page Start: P151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P4‐234: IMPROVED VASCULAR REACTIVITY AND REDUCED CEREBRAL AMYLOID ANGIOPATHY FOLLOWING PASSIVE IMMUNOTHERAPY IN TRANSGENIC MICE. (1st July 2014) Authors: Bales, Kelly; O'Neill, Sharon; Pozdnyakov, Nikolay; Pan, Feng; Caouette, David; Pi, YeQing; Wood, Kathleen M.; Volfson, Dmitri; Cirrito, John; Han, Byung Hee; Johnson, Andrew; Zipfel, Gregory; Samad, Tarek Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 15 Page Start: P872 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P4‐315: Evaluating amyloid‐beta processing using novel gamma‐secretase modulators in preclinical animal models. (1st July 2015) Authors: Wood, Kathleen M.; Gonzales, Cathleen; Pan, Feng; Pozdnyakov, Nikolay; Marconi, Michael; Robshaw, Ashley; Riddell, David; Volfson, Dmitri; Pettersson, Martin; Hajos-Korcsok, Eva; Bales, Kelly R. Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 19 Page Start: P905 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P4–298: Understanding the target and evaluating the consequences of gamma‐secretase modulation from in vitro models to higher‐order species. (1st July 2013) Authors: Wood, Kathleen; Pozdnyakov, Nikolay; Sylvain, Emily; Marconi, Michael; Robshaw, Ashley; Pustilnik, Leslie; Steyn, Stefanus; Trapa, Patrick; Lu, Yasong; Johnson, Douglas; Pettersson, Martin; Bales, Kelly Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 20 Page Start: P814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P4–299: Chronic ponezumab treatment reduces brain vascular amyloid in the PS1APP mouse model. (1st July 2013) Authors: O'Neill, Sharon; Pozdnyakov, Nikolay; YeQing Pi, ; Caouette, David; Wood, Kathleen; Wentland, Jo‐Ann; Bednar, Martin; Bales, Kelly; Samad, Tarek Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 20 Page Start: P814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P4–300: Developing an in vitro‐in vivo model to study the impact of increasing brain APOE levels on cardiovascular safety. (1st July 2013) Authors: Sylvain, Emily; Jatkar, Aditi; Marconi, Michael; Pozdnyakov, Nikolay; Duerr, James; Sawant, Aarti; Cianfrogna, Julie; Monetti, Mara; Miller, Russell; Goodwin, Bryan; LaChapelle, Erik; Pettersson, Martin; Ramaswamy, Gayathri; Bales, Kelly Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 20 Page Start: P814 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity. (22nd October 2015) Authors: Bales, Kelly R.; O'Neill, Sharon M.; Pozdnyakov, Nikolay; Pan, Feng; Caouette, David; Pi, YeQing; Wood, Kathleen M.; Volfson, Dmitri; Cirrito, John R.; Han, Byung-Hee; Johnson, Andrew W.; Zipfel, Gregory J.; Samad, Tarek A. Journal: Brain Issue: Volume 139:Part 2(2016:Feb.) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗